Evidence map›Paper›PMID 39881911›Full record

ArticleCureus2024

Linezolid-Induced Lactic Acidosis: A Case Report.

Moiuz Chaudhri, Eric Costanzo, Nusha Fareen, Mayurkumar Patel

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Moiuz ChaudhriInternal Medicine, Ocean University Medical Center, Hackensack Meridian Health, Brick, USA.
Eric CostanzoPulmonary and Critical Care Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA.
Nusha FareenInternal Medicine, Ocean University Medical Center, Hackensack Meridian Health, Brick, USA.
Mayurkumar PatelNephrology, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Linezolid, an oxazolidinone antibiotic, is widely used to treat infections caused by gram-positive bacteria that are resistant to other antibiotics. It inhibits bacterial protein synthesis by targeting rRNA. Although generally safe when used for short durations in uncomplicated patients, prolonged use may lead to adverse effects. Here, we present the case of a 66-year-old female with a complex orthopedic history, who developed a prosthetic knee infection unresponsive to other antibiotics. Consequently, she was treated with an extended course of linezolid therapy, which resulted in the development of lactic acidosis despite normal liver and kidney function.

Indexed as

lactic acidosislftslinezolidmitochondriamrsa

Identifiers

PMID39881911
PMCPMC11776439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.